Article information
Full text is only aviable in PDF
Bibliografia
[1.]
J. Pujol, J. Boher, J. Grenier, et al.
Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients.
Lung Cancer, 31 (2001), pp. 221-231
[2.]
C.F. Mountain.
Revisions in the international system for staging lung cancer.
Chest, 111 (1997), pp. 1710-1717
[3.]
D. Ferrigno, G. Buccheri, C. Giordano.
Neuron-specific enolase is an effective tumour marker in non-small cell lung cancer (NSCLC).
Lung Cancer, 41 (2003), pp. 311-320
[4.]
J.-L. Pujol, O. Molinier, W. Ebert, J.-P. Daurès, F. Barlési, G. Buccheri, M. Paesmans, E. Quoix, D. Moro-Sibilot, M. Szturmowicz, J.-M. Bréchot, T. Muley, J. Grenier.
Cyfra 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients.
Br J Cancer, 90 (2004), pp. 2097-2105
[5.]
Y. Sakao, S. Tomimitsu, Y. Takeda, M. Natsuaki, T. Itob.
Carcinoembryonic antigen as a predictive factor for postoperative tumour relapse in early-stage lung adenocarcinoma.
Eur J Cardio-thorac Surg, 25 (2004), pp. 520-522
[6.]
G. Buccheri, D. Ferrigno.
Prognostic factors.
Hematol Oncol Clin N Am, 18 (2004), pp. 187-201
[7.]
Société de Pneumologie de Langue Française.
Recommandations concernant l’utilisation des marqueurs tumoraux sériques dans la prise en charge des cancers bronchiques primitifs.
Rev Mal Respir, 14 (1997), pp. 5-9
Copyright © 2005. Sociedade Portuguesa de Pneumologia/SPP
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publish in
Pulmonology
Pulmonology
- Home
- All contents
- Publish your article
- About the journal
- Metrics
- Open access
Article options